Gonorrhoea and the sulphonamides.
作者信息
DUNLOP E M C
出版信息
Br J Vener Dis. 1949 Jun;25(2):81-3.
Abstract
摘要
相似文献
1
Gonorrhoea and the sulphonamides.淋病与磺胺类药物
Br J Vener Dis. 1949 Jun;25(2):81-3.
2
[Sulfonamides in treatment of Gonorrhea].[磺胺类药物治疗淋病]
Pol Tyg Lek (Wars). 1947;2(4):108-12.
3
[Results in the treatment of gonorrhea with sulphanilamides].
Pol Tyg Lek (Wars). 1947;2(2):39-42.
4
[Female gonorrhea and sulfamido therapy].[女性淋病与磺胺疗法]
Ann Ital Dermatol Sifilogr. 1947 Mar-Apr;2(5):424-7.
5
[Gonorrhea resistant to sulfonamide].
Dermatologica. 1949;98(2):115.
6
[Sulfamidotherapy in acute gonorrhea].[急性淋病的氨苯磺胺疗法]
Mem Soc Urug Urol. 1946;7(7):190-8.
7
[Studies On the Combined Sulfonamide Fever Treatment Of Gonorrhea].[淋病联合磺胺类药物发热治疗的研究]
Ned Tijdschr Geneeskd. 1948 Feb 7;92(6):400-10.
8
[Sulfadiazine Therapy for gonorrhea in case of failure with other sulfonamide preparations].[在其他磺胺类制剂治疗淋病失败的情况下，用磺胺嘧啶进行治疗]
Wien Klin Wochenschr. 1946 Sep 6;58(32):518-20.
9
Urea as an adjunct to sulfonamide therapy.尿素作为磺胺类药物治疗的辅助药物。
J Lab Clin Med. 1946 Apr;31:444-52.
10
Treatment of sulphonamide-resistant gonorrhoea by penicillin.用青霉素治疗耐磺胺淋病
Br Med J. 1946 Apr 20;1:605.
引用本文的文献
1
Structure-Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against .基于乙酰唑胺的碳酸酐酶抑制剂与. 的活性的构效关系研究
ACS Infect Dis. 2021 Jul 9;7(7):1969-1984. doi: 10.1021/acsinfecdis.1c00055. Epub 2021 Mar 25.
2
The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae.解决淋病奈瑟菌抗生素耐药性的前沿问题。
Transl Res. 2020 Jun;220:122-137. doi: 10.1016/j.trsl.2020.02.002. Epub 2020 Feb 29.
3
Murine host response to Neisseria gonorrhoeae upper genital tract infection reveals a common transcriptional signature, plus distinct inflammatory responses that vary between reproductive cycle phases.淋病奈瑟菌引起的上生殖道感染对鼠类宿主的影响揭示了一个共同的转录特征，以及在生殖周期各阶段存在不同的炎症反应。
BMC Genomics. 2018 Aug 22;19(1):627. doi: 10.1186/s12864-018-5000-7.
4
Applications of genomics to slow the spread of multidrug-resistant Neisseria gonorrhoeae.基因组学在减缓耐多药淋病奈瑟菌传播中的应用。
Ann N Y Acad Sci. 2019 Jan;1435(1):93-109. doi: 10.1111/nyas.13871. Epub 2018 Jun 6.
5
Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century.淋病奈瑟菌的耐药性：21 世纪全球主要公共卫生问题。
Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.EI10-0009-2015.
6
The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.病原体库以及使它们失去毒性的抗毒力治疗策略。
Drug Des Devel Ther. 2016 May 27;10:1795-806. doi: 10.2147/DDDT.S98939. eCollection 2016.
7
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.21世纪淋病奈瑟菌的抗菌药物耐药性：过去、演变及未来
Clin Microbiol Rev. 2014 Jul;27(3):587-613. doi: 10.1128/CMR.00010-14.
8
Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future.淋病奈瑟菌的抗生素耐药性：起源、进化以及对未来的启示。
Ann N Y Acad Sci. 2011 Aug;1230:E19-28. doi: 10.1111/j.1749-6632.2011.06215.x.
9
Treatment problems of gonorrhoea.淋病的治疗问题。
Bull World Health Organ. 1961;24(3):307-19.
10
Possible effects of antibiotic treatment on the senstivity and growth requirements of Neisseria gonorrhoea.抗生素治疗对淋病奈瑟菌敏感性和生长需求的可能影响。
Bull World Health Organ. 1961;24(3):333-42.
Zotero 插件